Activation of PGC-1α-dependent mitochondrial biogenesis supports therapeutic effects of silibinin against type I diabetic periodontitis (Journal of Clinical Periodontology; doi: 10.1111/jcpe.13811)
Xiaoyu Sun, Yifan Ping, Xumin Li, Yixin Mao, Yang Chen, Lixi Shi, Xinhua Hong, Liang Chen, Shuhong Chen, Zelin Cao, Pan Chen, Zhongchen Song, Daniel Wismeijer, Gang Wu, Yinhui Ji, Shengbin Huang
Cells need functioning energy-producing structures, called mitochondria, to stay healthy. Researchers studied whether protecting these structures could reduce gum damage associated with diabetes.
The experiments used rats with induced diabetes and periodontitis, together with human periodontal cells grown in a laboratory. Scientists tested silibinin, a plant-derived compound, and examined a protein involved in producing and maintaining mitochondria.
Some treated rats had less bone loss around teeth and fewer signs of cell damage. Laboratory cells also showed improved energy-related measurements and survival. Interfering with the protein pathway weakened these effects, suggesting it was involved. These findings concern selected doses and controlled experimental conditions, not people taking a plant supplement.
The work may identify a direction for future treatment development. It does not show that silibinin or milk-thistle products will improve gum health in people with diabetes. Laboratory-grown human cells cannot establish a patient’s treatment response, and the model mainly resembled insulin-deficient diabetes. Before considering clinical use, researchers would need to establish how the compound should be delivered, whether it is safe and whether it adds a meaningful benefit to usual care.
Animal and laboratory studies allow researchers to investigate processes that cannot easily be tested in people. However, experimentally induced diabetes or gum damage does not reproduce every aspect of human disease. The timing, exposure and biological responses may differ substantially. A promising effect in this setting needs further testing for both benefit and harm before it can inform patient treatment. This paper therefore helps explain a possible mechanism; it does not establish an effective human treatment or a safe dose of an experimental substance.
Read the full article Back to Research
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
Periodontitis is the 6th most prevalent condition globally
Periodontitis and diabetes are bidirectionally linked
Diabetic complications are increased if you have both diseases
Successful periodontal treatment can improve blood glucose control
